EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

Nitric oxide oxidation products in the serum of patients with gastric and esophageal cancer and Helicobacter pylori

M. Kürşat TÜRKDOĞAN ¹ , Haluk TESTERECİ ² , Tahir KAHRAMAN ² , F. Hüsniye DİLEK ³ , Emel AKMAN ⁴

Author Affiliation(s)

1.

Yüzüncü Yıl Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı, Van

2.

Yüzüncü Yıl Üniversitesi Veteriner Fakültesi Biyokimya Anabilim Dalı, Van

3.

Yüzüncü Yıl Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı ve Patoloji Anabilim Dalı, Van

4.

Yüzüncü Yıl University, Medical Faculty, Departments of Internal Medicine and Pathology, Van

Turk J Gastroenterol 1999; 10: 193-196

Keywords : Nitric oxide, Helicobacter pylori, gastric cancer

Read: 1489 Published: 25 July 2019

Volume 10, Issue 3, September 1999

Previous Article